Home » Pharma » Top 20 Pharma Companies based on R&D Investments in 2015-16

Top 20 Pharma Companies based on R&D Investments in 2015-16

  1. Novartis. It spent $11.2 billion in R&D in 2015-16 fiscal year.
  2. Roche. The company invested $10.7 billion in R&D in 2015-16.
  3. Johnson & Johnson. It spent $10.3 billion last fiscal year in R&D.
  4. Pfizer. Its R&D spending reached $8.78 billion in 2015-16.
  5. Merck. In fiscal year 2015-16, the company spent $8.03 billion in R&D.
  6. Bristol-Myers Squibb. It spent $6.59 billion in R&D in the last fiscal year.
  7. Sanofi. The company spent $6.54 billion in R&D in the fiscal year 2015-16.
  8. AstraZeneca. Its R&D spending reached $6.50 billion in 2015-16.
  9. Bayer. It spent $5.53 billion in R&D in the last fiscal year.
  10. GlaxoSmithKline. The company’s R&D spending reached $5.25 billion in 2015-16 fiscal year.
  11. Abbvie ($4.86 billion)
  12. Eli Lilly ($4.56 billion)
  13. Amgen ($4.51 billion)
  14. Celgene ($4.23 billion)
  15. Boehringer Ingelheim ($3.74 billion)
  16. Gilead Science ($2.77 billion)
  17. Takeda ($3.29 billion)
  18. Allergan ($3.06 billion)
  19. Biogen ($2.30 billion)
  20. Novo Nordisk ($2.17 billion)

 

Reference

 

EU Scoreboard 2016 (World 2500)

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*